Table 2.
Summary of articles included in our review.
| Title | Type of topical treatment | Patients (n) | Response | Follow up |
|---|---|---|---|---|
| Piraccini et al.17 | Propanolol 1% cream, once daily, under occlusion for a maximum of 45 days | 10 | CR: 3/10 PR: NA NR: 7/10 |
– |
| Cubiró et al.18 | Timolol 0.5% gel, twice daily, under occlusion, for 1 month | 10 | CR: 9/10 PR: 1/10 NR: NA |
8 months |
| Sibaud et al.19 | Timolol 0.5% gel, twice daily, under occlusion for 1 month | 13 | CR: 2/13 PR: 6/13 NR: 5/13 |
– |
| Yen et al.20 | Betaxolol 0.25% eye drops, once daily, under occlusion for 1 month | 1 | CR: 1/1 PR: NA NR: NA |
– |
CR, complete response; NA, not applicable; NR, no response; PR, partial response.